Researchers at the University of North Carolina have discovered a subset of cells called TH17 that trigger the immune system to attack transplanted cells, Medical News Today reports. The finding could help chart a course to therapies that may prevent graft-versus-host disease. “Our hope is that uncovering the mechanisms that cause graft-versus-host disease will allow [Sign in to read the full article...]